advertisement
Xing X 10
Showing records 1 to 10 | Display all abstracts from Xing X106140 Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Hao H; Hao H
Biomaterials advances 2022; 142: 213162
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Sun X; Yao K
Ophthalmology and therapy 2023; 12: 341-353
106140 Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
He B; Yu B
Biomaterials advances 2022; 142: 213162
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Liu Q
Ophthalmology and therapy 2023; 12: 341-353
106140 Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Yang J
Biomaterials advances 2022; 142: 213162
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Zhang H; Xing X
Ophthalmology and therapy 2023; 12: 341-353
106140 Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Xing X
Biomaterials advances 2022; 142: 213162
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Fang A
Ophthalmology and therapy 2023; 12: 341-353
106140 Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Liu W
Biomaterials advances 2022; 142: 213162
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Duan X; Yu M; Chen MY; Yang J; Goodkin ML
Ophthalmology and therapy 2023; 12: 341-353
